News & Events
15 April 2019
Marta Fructuoso joins HEROES project
Marta Fructuoso joined the HEROES project on February 2018 as a postdoctoral researcher in Dr. Poitier’s team (Partner 2). Her research aims at investigating whether a defect in the endo-lysosomal pathway in neurons from the locus coeruleus may be a shared mechanism contributing to dementia in neurodegenerative diseases such as Alzheimer disease, Parkinson disease, and Down syndrome. She will...
15 April 2019
Maartje de Vries joins HEROES project
Maartje de Vries, MSc joined the HEROES project on October 2018 as a PhD student at the University Medical Center Groningen (UMCG) Alzheimer Center in the Netherlands (Partner 4; lead by Prof. Dr. P. De Deyn). She will be involved in performing neuroimaging in patients, using positron emission tomography (PET) to characterize the noradrenergic system in vivo. Since evidence shows that noradrene...
02 December 2018
The Down syndrome ECNP network met at the ECNP congress 2018
The Down syndrome ECNP network met at the ECNP congress 2018 in Barcelona on the 8th of October 2018. Marie-Claude Potier presented an update of the achievements obtained during the last year. A preclinical and clinical research project leaded by Prof Renata Bartesaghi was presented focusing on improving cognitive performance after promoting neurogenesis in Down syndrome mouse models and patien...
02 December 2018
Second follow-up meeting of HEROES project was held on the 8th of October 2018
The HEROES team met in Barcelona for the second follow-up meeting on the 8th of October 2018 at the ECNP 2018 congress. Good progress continues to be made across the different work streams and protocols are setting up to share and work with brain and blood samples. Ethical approvals have been obtained for most of the procedures, and thus, the experiments will carry on soon. Moreover, HEROES tea...
23 September 2018
SfN-Sponsored Social proposal, “Down Syndrome: From Neurobiology to Treatment"
SfN Monday 5th November from 6.45pm to 8.45pm
There’s a lot happening in Down syndrome, the most common genetic form of intellectual disability and the single biggest risk factor for Alzheimer’s disease. This is an opportunity to socialise with a range of scientists and clinicians coming from across the neuroscience spectrum and with a common interest in the neurobiology of Down s...